PPARGC1A and obesity disorder: The major SCFAs reduce lipogenesis and increase fatty acid oxidation, thermogenesis, and adipocyte browning in adipose tissue, muscle, and liver by increasing the expression of PGC1α, UCP1, and AMPK activation, which appear to have anti-obesity effects.